SAN CARLOS, Calif. & LISBON, Portugal--March 7, 2024--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it will present additional positive Phase 2a...
Scott Weiner to join panel at 2nd Annual Global Healthcare Investing Conference
News | 04. 30. 2008
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.